Joan Garcı́a

2.4k total citations
51 papers, 1.5k citations indexed

About

Joan Garcı́a is a scholar working on Hematology, Surgery and Genetics. According to data from OpenAlex, Joan Garcı́a has authored 51 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Hematology, 19 papers in Surgery and 13 papers in Genetics. Recurrent topics in Joan Garcı́a's work include Hematopoietic Stem Cell Transplantation (24 papers), Mesenchymal stem cell research (12 papers) and Coronary Interventions and Diagnostics (7 papers). Joan Garcı́a is often cited by papers focused on Hematopoietic Stem Cell Transplantation (24 papers), Mesenchymal stem cell research (12 papers) and Coronary Interventions and Diagnostics (7 papers). Joan Garcı́a collaborates with scholars based in Spain, United Kingdom and France. Joan Garcı́a's co-authors include Luciano Rodrı́guez, Ignasi Bolíbar, Iván Solà, José A. Expósito, María José Martínez‐Zapata, Arturo J Martí-Carvajal, Carlos Zaror, Sergio Querol, Òscar Fornas and Arturo J Martí-Carvajal and has published in prestigious journals such as Nature Medicine, Blood and Development.

In The Last Decade

Joan Garcı́a

49 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joan Garcı́a Spain 21 472 337 330 273 272 51 1.5k
G. Crovetti Italy 7 175 0.4× 906 2.7× 194 0.6× 346 1.3× 203 0.7× 11 2.0k
Attila Szakos Sweden 11 357 0.8× 198 0.6× 515 1.6× 1.0k 3.8× 78 0.3× 20 1.6k
Eva Zetterberg Sweden 15 457 1.0× 205 0.6× 704 2.1× 1.3k 4.9× 134 0.5× 51 2.0k
Lindsay C. Davies Sweden 19 125 0.3× 184 0.5× 449 1.4× 820 3.0× 102 0.4× 41 1.5k
Juan F. Blanco Spain 21 438 0.9× 378 1.1× 611 1.9× 603 2.2× 214 0.8× 62 1.8k
A Bussel France 21 598 1.3× 220 0.7× 155 0.5× 376 1.4× 74 0.3× 82 1.8k
D. Weber Switzerland 31 1.1k 2.4× 843 2.5× 852 2.6× 393 1.4× 530 1.9× 103 3.0k
Craig Donaldson United Kingdom 20 627 1.3× 323 1.0× 438 1.3× 830 3.0× 55 0.2× 45 2.1k
Isabel Colmenero Spain 15 115 0.2× 185 0.5× 394 1.2× 485 1.8× 56 0.2× 57 1.5k
Michel Toungouz Belgium 27 200 0.4× 393 1.2× 893 2.7× 1.3k 4.6× 75 0.3× 65 2.5k

Countries citing papers authored by Joan Garcı́a

Since Specialization
Citations

This map shows the geographic impact of Joan Garcı́a's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joan Garcı́a with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joan Garcı́a more than expected).

Fields of papers citing papers by Joan Garcı́a

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joan Garcı́a. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joan Garcı́a. The network helps show where Joan Garcı́a may publish in the future.

Co-authorship network of co-authors of Joan Garcı́a

This figure shows the co-authorship network connecting the top 25 collaborators of Joan Garcı́a. A scholar is included among the top collaborators of Joan Garcı́a based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joan Garcı́a. Joan Garcı́a is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Balayo, Tina, Sharna Lunn, Ulla-Maj Fiúza, et al.. (2025). N2B27 media formulations influence gastruloid development. Development. 152(22).
2.
Vives, Joaquim, Margarita Codinach, Ruth Coll, et al.. (2015). Development of an advanced cell therapy product indicated for the treatment of gonarthrosis. BMC Proceedings. 9(S9). 6 indexed citations
3.
4.
Karjalainen, Pasi P., Joan Garcı́a, José Francisco Díaz Fernández, et al.. (2010). The EXTREME registry: Titanium‐nitride‐oxide coated stents in small coronary arteries. Catheterization and Cardiovascular Interventions. 76(2). 281–287. 5 indexed citations
5.
Querol, Sergio, G J Mufti, Steven G. E. Marsh, et al.. (2009). Cord blood stem cells for hematopoietic stem cell transplantation in the UK: how big should the bank be?. Haematologica. 94(4). 536–541. 47 indexed citations
6.
Martínez‐Zapata, María José, Arturo J Martí-Carvajal, Iván Solà, et al.. (2008). Efficacy and safety of the use of autologous plasma rich in platelets for tissue regeneration: a systematic review. Transfusion. 49(1). 44–56. 110 indexed citations
7.
Astori, Giuseppe, Jérôme Larghero, Raffaella Giancola, et al.. (2006). Ex vivo expansion of umbilical cord blood CD34+ cells in a closed system: a multicentric study. Vox Sanguinis. 90(3). 183–190. 9 indexed citations
8.
Rodrı́guez, Luciano, Joan Garcı́a, & Sergi Querol. (2005). Predictive utility of the attached segment in the quality control of a cord blood graft. Biology of Blood and Marrow Transplantation. 11(4). 247–251. 26 indexed citations
9.
Martı́, Vicens, et al.. (2002). Coronary endothelial dysfunction and myocardial cell damage in chronic stable idiopathic dilated cardiomyopathy. International Journal of Cardiology. 82(3). 237–245. 14 indexed citations
10.
Martı́, Vicens, et al.. (2001). Twelve-month outcome after coronary stent implantation without predilatation. The American Journal of Cardiology. 88(7). 788–792. 1 indexed citations
11.
Ferrá, Christelle, David Gallardo, Maite Encuentra, et al.. (2001). Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplantation. 28(10). 963–968. 16 indexed citations
12.
Amill, B, et al.. (2001). Combined positive and negative cell selection from allogeneic peripheral blood progenitor cells (PBPC) by use of immunomagnetic methods. Bone Marrow Transplantation. 27(7). 683–687. 10 indexed citations
13.
Querol, Sergio, et al.. (2000). Direct immunomagnetic method for CD34+ cell selection from cryopreserved cord blood grafts for ex vivo expansion protocols. Transfusion. 40(6). 625–631. 23 indexed citations
14.
Grañena, A, Xavier Castellsagué, Isabel Badell, et al.. (1999). Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement. Bone Marrow Transplantation. 24(6). 621–627. 22 indexed citations
15.
González‐Barca, Eva, A Grañena, A. Fernández‐Sevilla, et al.. (1999). Low‐dose subcutaneous interleukin‐2 in patients with minimal residual lymphoid neoplasm disease. European Journal Of Haematology. 62(4). 231–238. 7 indexed citations
16.
Amill, B, Garth Fraga, Isabel Badell, et al.. (1997). Immunomagnetic Bone Marrow Purging in Children with Acute Lymphoblastic Leukemia. Journal of Hematotherapy. 6(3). 261–268. 8 indexed citations
17.
Ferrá, Christelle, S de Sanjosé, Francesc Martí, et al.. (1997). Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications. Bone Marrow Transplantation. 20(12). 1075–1080. 43 indexed citations
18.
Garcı́a, Joan, et al.. (1994). Bone Marrow Purging in Acute Lymphoblastic Leukemia: Biological and Clinical Features. Journal of Hematotherapy. 3(3). 203–211. 14 indexed citations
19.
Sierra, Jorge, A Grañena, Joan Garcı́a, et al.. (1993). Autologous bone marrow transplantation for acute leukemia: results and prognostic factors in 90 consecutive patients.. PubMed. 12(5). 517–23. 21 indexed citations
20.
McPhedran, Peter, Clark W. Heath, & Joan Garcı́a. (1972). Multiple Myeloma Incidence in Metropolitan Atlanta, Georgia: Racial and Seasonal Variations. Blood. 39(6). 866–873. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026